Shilajit and Blood Pressure: Does It Raise or Lower BP? (2026)

Does shilajit raise or lower blood pressure?

The overall direction of the evidence suggests shilajit is more likely to lower blood pressure than raise it. But the evidence is thin, and the answer depends on who is taking it and what else is happening in their body.

The primary mechanism is antioxidant-mediated protection of nitric oxide (NO). In healthy blood vessels, endothelial cells produce NO, which signals smooth muscle in artery walls to relax, widening the vessel and reducing resistance to blood flow. Oxidative stress destroys NO before it can do this job, leading to stiffer arteries and higher blood pressure. Shilajit's fulvic acid is a potent antioxidant that may reduce this oxidative degradation of NO, preserving its vasodilatory function (Carrasco-Gallardo et al., 2012, PubMed). Fulvic acid makes up 50 to 80 percent of purified shilajit and is the compound behind most of its studied effects; see what is shilajit for the full breakdown. The 2014 safety and efficacy review noted shilajit's adaptogenic properties, including its antioxidant capacity, as a plausible mechanism for cardiovascular effects (Stohs et al., 2014, PubMed).

This is a mechanistic argument, not proof. No large trial has measured blood pressure as its primary outcome in response to shilajit. The evidence that exists comes from smaller studies where blood pressure or vascular function was a secondary measure, and from one adverse case report that documented the opposite effect.

The human evidence: what trials actually measured

Vascular function and endothelial markers. The most relevant evidence comes from studies measuring how shilajit affects the blood vessels themselves, rather than blood pressure numbers alone. Small randomized studies in patients with type 2 diabetes and in elderly hypertensive patients have reported that purified shilajit (250 to 500 mg twice daily for 12 weeks and 30 days respectively) improved endothelial function, increased nitric oxide levels, and reduced oxidative stress markers such as malondialdehyde while raising antioxidant capacity. These studies were published in regional journals and have small samples, so they sit at the lower end of the evidence hierarchy. The proposed mechanism aligns with what is better documented: shilajit's fulvic acid is a potent antioxidant that may preserve nitric oxide bioavailability, supporting healthier vascular tone (Carrasco-Gallardo et al., 2012, PubMed; Stohs et al., 2014, PubMed).

Important limits: these measured vascular function markers (endothelial function, nitric oxide, arterial stiffness), not blood pressure reduction directly. "Improved arterial stiffness" and "lower blood pressure" are related but not identical outcomes. This line of research cannot be used to claim that shilajit lowers blood pressure in a clinically meaningful way.

The large metabolic-syndrome trial. The biggest and most rigorous recent study to include shilajit was a 2025 randomized, double-blind, placebo-controlled trial of 166 adults with metabolic syndrome risk factors, run at Texas A&M University (Martinez et al., 2025, Nutrients, PubMed). Participants combined a 12-week exercise and diet program with supplementation. This trial is important precisely because of what it does not show for shilajit specifically: shilajit was one minor component (6 to 12 mg per day) of a multi-ingredient formula that also contained chromium and Phyllanthus emblica (amla). You cannot isolate shilajit's individual contribution to any cardiometabolic outcome from this design, and the shilajit dose was far below the 250 to 500 mg used in the vascular studies. It is a reminder that most "shilajit cardiovascular" marketing rests on either small regional studies or multi-ingredient trials, not large, shilajit-specific, blood-pressure-focused RCTs, of which none exist.

The testosterone trial's safety data. Pandit et al. (2016) monitored safety parameters including blood pressure throughout their 90-day testosterone trial in 96 healthy men aged 45 to 55. No clinically significant blood pressure changes were reported in either the shilajit or placebo groups (PubMed). This is reassuring: at 500 mg/day for 90 days, shilajit did not cause problematic blood pressure changes in healthy men. But it also means this trial showed no blood-pressure-lowering benefit either.

The pregnancy case report. Stavropoulos et al. (2018) described a 37-year-old pregnant woman who developed persistent hypertension and hypokalemia (low potassium) after consuming mumijo (shilajit) for six months. The diagnosis was pseudohyperaldosteronism, a "licorice-like syndrome" caused by inhibition of the enzyme 11-beta-hydroxysteroid dehydrogenase type 2 (11-HSD2). When shilajit was discontinued and potassium was supplemented, the condition resolved (Gynecological Endocrinology, PubMed).

A case report is the weakest form of clinical evidence, and this is literally one patient. But it is significant because it documents a specific, named mechanism (11-HSD2 inhibition leading to cortisol accumulation and mineralocorticoid excess) by which shilajit could raise blood pressure in susceptible individuals. This is the same pathway through which licorice root causes hypertension, and it is well understood pharmacologically. Whether this applies to non-pregnant adults at typical supplemental doses is unknown. Pregnancy alters hormone metabolism dramatically, and the patient had been taking shilajit for six months, so the circumstances are not generalizable. Still, the mechanism is real, and it means "shilajit always lowers blood pressure" is an oversimplification.

Does shilajit raise blood pressure?

In most contexts, no. The available human data and the dominant mechanism (antioxidant protection of nitric oxide) point toward a hypotensive, not hypertensive, effect. But the Stavropoulos case report proves that a pathway exists through which shilajit can raise blood pressure in at least some circumstances.

The honest answer is: shilajit's effect on blood pressure is probably mildly hypotensive in most people, potentially hypertensive in rare cases (especially pregnancy), and has not been studied rigorously enough in either direction to make strong claims. If you have normal blood pressure and no relevant medications, shilajit at standard doses (250 to 500 mg/day) is unlikely to cause a problem. If your blood pressure is already a clinical concern, in either direction, you need medical guidance before adding shilajit to your routine.

Who should be cautious

Several groups should consult a healthcare provider before taking shilajit because of its potential effects on blood pressure and mineral balance.

People on antihypertensive medication. If shilajit lowers blood pressure even modestly, it could compound the effect of your medication, pushing blood pressure too low. Symptoms include dizziness, lightheadedness, and fainting. Do not start shilajit without discussing it with the prescribing physician.

People with hypotension (low blood pressure). If your blood pressure is already low, any further reduction could cause problems. This is uncommon as a concern, but worth mentioning for people who experience chronic low blood pressure.

Pregnant or breastfeeding women. The Stavropoulos case report is the primary reason. Even without this case, no safety data exists for shilajit in pregnancy, and shilajit is not recommended during pregnancy or breastfeeding under any circumstances. The 11-HSD2 inhibition mechanism demonstrated in that case is a genuine risk in the hormonal context of pregnancy.

People with kidney conditions. Shilajit's mineral content and its effect on potassium (as seen in the case report) make it worth discussing with a nephrologist if you have existing kidney disease. For the full safety breakdown, see shilajit side effects.

What this means practically

Shilajit is not a blood pressure supplement. It is not an alternative to medication. It is a mineral-and-fulvic-acid supplement whose cardiovascular effects are a secondary consequence of its antioxidant activity, not a primary purpose.

If you are considering shilajit for general wellness, testosterone support, or exercise recovery (its better-studied uses, covered in does shilajit actually work), blood pressure is something to be aware of, not something to target. Monitor your blood pressure if you start shilajit, especially during the first few weeks. If you notice dizziness, lightheadedness, or blood pressure readings that are unusually low for you, stop and consult your doctor.

For dosing guidance, see how much shilajit to take. For timing, see best time to take shilajit. For tested product recommendations, start there.

What to monitor if you take shilajit with cardiovascular concerns

If you decide to take shilajit while managing blood pressure or cardiovascular health, tracking a few basic numbers will help you and your doctor evaluate whether it is safe to continue.

Home blood pressure readings. Take readings at the same time each day, ideally morning before eating or taking medications. Record both systolic and diastolic values. If systolic drops more than 10 mmHg below your usual baseline, or if you experience dizziness or lightheadedness, stop shilajit and consult your doctor before resuming. A consistent pattern of lower readings over two weeks is the signal to discuss with your provider, whether that is a good development or a concerning one depends on your starting point.

Potassium levels. The Stavropoulos case report documented hypokalemia from shilajit use. If you are already taking medications that affect potassium (ACE inhibitors, ARBs, diuretics), adding shilajit creates a more complex electrolyte picture. Ask your doctor to include potassium in routine bloodwork during the first 8 to 12 weeks of shilajit supplementation.

Heart rate. Some users report a mild calming effect, which could reflect reduced sympathetic tone or simply reduced oxidative stress. Track resting heart rate alongside blood pressure. A sudden resting heart rate increase or irregularity warrants medical attention regardless of supplement use.

Kidney function markers. Shilajit contains trace minerals that the kidneys must process. For people with existing kidney concerns, a standard metabolic panel (BUN, creatinine, eGFR) during routine checkups provides a baseline for comparison. This is general good practice for any mineral-containing supplement, not a shilajit-specific warning.

For the recommended dose range and duration aligned with clinical trial protocols, see shilajit dosage.

Can shilajit replace blood pressure medication?

No. Shilajit is not a blood pressure medication and should never be used as a replacement for prescribed antihypertensive therapy.

Antihypertensive drugs (ACE inhibitors, ARBs, calcium channel blockers, beta-blockers, diuretics) have been tested in trials with thousands of patients over decades. They have documented, dose-dependent effects on blood pressure reduction and cardiovascular event prevention. Shilajit has one small vascular-function study and one case report. The evidence levels are incomparable. Stopping prescribed medication in favor of a supplement is dangerous and could lead to stroke, heart attack, or kidney damage. If you want to explore shilajit as a complement to your existing regimen, discuss it with your prescriber first. Never stop or reduce medication on your own.

Why purity matters even more for cardiovascular safety

Heavy-metal contamination in shilajit products is a safety concern for everyone, but for anyone with cardiovascular issues, it is a direct risk factor.

Lead and cadmium are both known to raise blood pressure through vascular damage and oxidative stress, the exact opposite of what fulvic acid is supposed to do. A contaminated shilajit product could actively worsen cardiovascular health while claiming to support it. A 2025 analysis detected thallium in five of six commercial products tested (Kamgar et al., 2025, PubMed), and a 2022 study confirmed significant variation in heavy metals across products from different sources (Aldakheel et al., 2022, PubMed).

The rule for any shilajit buyer is non-negotiable: only use products with batch-specific third-party heavy-metal testing from an accredited lab. For people with cardiovascular concerns, this rule carries even more weight. See best shilajit supplements for tested options.

Why we sell capsules, not blood pressure claims

Our Shilajit Adaptogen Complex is formulated for general wellness, not cardiovascular treatment. We test every batch for heavy metals to ensure the product does not introduce the very contaminants that would undermine cardiovascular health. We do not make blood pressure claims because the evidence does not support them.

Tested. Transparent. No overpromises. Explore Shilajit Adaptogen Complex →

Our Batch-Level Purity Testing

Manufactured in a UL Solutions GMP-certified facility (certification valid through November 12, 2028). Every batch undergoes independent third-party testing. Lot 6010323 (COA issued 06/18/2026) passed every safety threshold.

Full batch results: yourhealthier.com/pages/lab-results.

Testing & Transparency Methodology

Every YourHealthier product is manufactured in an FDA-registered facility and undergoes independent third-party testing at accredited laboratories using validated USP, AOAC, and ICP-MS methods. All testing complies with 21 CFR Part 111. This article is for educational purposes and is not medical advice; it has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

Related reading: shilajit drug interactions.

References

Frequently asked questions

This statement has not been evaluated by the Food and Drug Administration. This article is for informational purposes only and is not medical advice. Shilajit is a dietary supplement and is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before starting shilajit, especially if you take medication for blood pressure, have a cardiovascular condition, or are pregnant or breastfeeding. YourHealthier manufactures and sells shilajit products discussed here.